<code id='35989C3C1E'></code><style id='35989C3C1E'></style>
    • <acronym id='35989C3C1E'></acronym>
      <center id='35989C3C1E'><center id='35989C3C1E'><tfoot id='35989C3C1E'></tfoot></center><abbr id='35989C3C1E'><dir id='35989C3C1E'><tfoot id='35989C3C1E'></tfoot><noframes id='35989C3C1E'>

    • <optgroup id='35989C3C1E'><strike id='35989C3C1E'><sup id='35989C3C1E'></sup></strike><code id='35989C3C1E'></code></optgroup>
        1. <b id='35989C3C1E'><label id='35989C3C1E'><select id='35989C3C1E'><dt id='35989C3C1E'><span id='35989C3C1E'></span></dt></select></label></b><u id='35989C3C1E'></u>
          <i id='35989C3C1E'><strike id='35989C3C1E'><tt id='35989C3C1E'><pre id='35989C3C1E'></pre></tt></strike></i>

          explore

          explore

          author:hotspot    Page View:7
          Novo Nordisk Denmark
          LISELOTTE SABROE/AFP/Getty Images

          A pill being developed by Danish drugmaker Novo Nordisk may lead to greater weight loss than the obesity therapy Wegovy, the company reported Thursday, citing early data.

          In a Phase 1 trial, participants experienced an average of 13.1% weight loss after 12 weeks of taking the experimental oral medicine amycretin, according to data presented at an investor meeting. In comparison, in an earlier Phase 3 trial of the injectable drug Wegovy, people taking Wegovy lost about 6% of their body weight over the same time period.

          advertisement

          Novo Nordisk has been on a mission to capitalize on its success with Wegovy, which brought in $4.5 billion in sales last year. (The drug is also sold as a diabetes treatment under the name Ozempic. That version of the drug brought in another $14 billion in sales).

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more
          Be careful with at
          Be careful with at

          AdobeHypertensionisconsideredtobetheNo.1riskfactorfordeathglobally.Soit’snowonderconvenient,relative

          read more
          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more

          CDC Director Mandy Cohen on transparency, trust, and health

          CDCDirectorMandyCohenCliffOwen/APThenewdirectoroftheCentersforDiseaseControlandPrevention,MandyCohen